Cibus (CBUS) Competitors $1.32 -0.05 (-3.65%) Closing price 08/25/2025 04:00 PM EasternExtended Trading$1.32 +0.00 (+0.38%) As of 09:06 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CBUS vs. AMTX, VGAS, FSI, LODE, ORGN, TSE, ALTO, ZTEK, LOOP, and BLGOShould you be buying Cibus stock or one of its competitors? The main competitors of Cibus include Aemetis (AMTX), Verde Clean Fuels (VGAS), Flexible Solutions International (FSI), Comstock (LODE), Origin Materials (ORGN), Trinseo (TSE), Alto Ingredients (ALTO), Zentek (ZTEK), Loop Industries (LOOP), and BioLargo (BLGO). These companies are all part of the "chemicals" industry. Cibus vs. Its Competitors Aemetis Verde Clean Fuels Flexible Solutions International Comstock Origin Materials Trinseo Alto Ingredients Zentek Loop Industries BioLargo Cibus (NASDAQ:CBUS) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations. Does the media refer more to CBUS or AMTX? In the previous week, Cibus had 8 more articles in the media than Aemetis. MarketBeat recorded 8 mentions for Cibus and 0 mentions for Aemetis. Cibus' average media sentiment score of 0.63 beat Aemetis' score of 0.00 indicating that Cibus is being referred to more favorably in the media. Company Overall Sentiment Cibus Positive Aemetis Neutral Is CBUS or AMTX more profitable? Aemetis has a net margin of -36.70% compared to Cibus' net margin of -5,681.55%. Aemetis' return on equity of 0.00% beat Cibus' return on equity.Company Net Margins Return on Equity Return on Assets Cibus-5,681.55% -83.67% -20.85% Aemetis -36.70%N/A -33.18% Which has preferable valuation and earnings, CBUS or AMTX? Aemetis has higher revenue and earnings than Cibus. Aemetis is trading at a lower price-to-earnings ratio than Cibus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCibus$4.26M16.81-$251.39M-$10.45-0.13Aemetis$267.64M0.63-$87.54M-$1.62-1.64 Do analysts recommend CBUS or AMTX? Cibus currently has a consensus target price of $22.00, indicating a potential upside of 1,566.67%. Aemetis has a consensus target price of $17.00, indicating a potential upside of 541.51%. Given Cibus' higher possible upside, equities analysts clearly believe Cibus is more favorable than Aemetis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cibus 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Aemetis 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in CBUS or AMTX? 33.8% of Cibus shares are owned by institutional investors. Comparatively, 27.0% of Aemetis shares are owned by institutional investors. 49.4% of Cibus shares are owned by insiders. Comparatively, 15.9% of Aemetis shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, CBUS or AMTX? Cibus has a beta of 1.75, meaning that its share price is 75% more volatile than the S&P 500. Comparatively, Aemetis has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500. SummaryCibus beats Aemetis on 9 of the 14 factors compared between the two stocks. Get Cibus News Delivered to You Automatically Sign up to receive the latest news and ratings for CBUS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CBUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBUS vs. The Competition Export to ExcelMetricCibusAGRI OPERATIONS IndustryStaples SectorNASDAQ ExchangeMarket Cap$74.31M$3.00B$16.47B$9.74BDividend YieldN/A3.53%3.04%4.08%P/E Ratio-0.1312.8618.4225.85Price / Sales16.815.6846.63104.01Price / Cash0.358.6415.1628.79Price / Book0.423.026.185.99Net Income-$251.39M$122.48M$680.19M$265.38M7 Day Performance-3.65%0.07%0.18%2.54%1 Month Performance-18.01%-11.12%-2.11%-0.13%1 Year Performance-81.79%-23.18%2.70%17.61% Cibus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBUSCibus3.2831 of 5 stars$1.32-3.6%$22.00+1,566.7%-82.5%$74.31M$4.26M-0.1348AMTXAemetis1.5993 of 5 stars$2.50+2.5%$17.00+580.0%+0.4%$158.10M$267.64M-1.54160VGASVerde Clean FuelsN/A$2.64-6.7%N/A-25.8%$117.61MN/A-6.442FSIFlexible Solutions International3.7293 of 5 stars$7.85flatN/A+183.3%$99.29M$37.32M23.7940Gap UpLODEComstock1.3868 of 5 stars$2.46+2.5%$4.00+62.6%+31.3%$87.29M$3.38M-20.5030ORGNOrigin Materials1.5956 of 5 stars$0.57+7.5%$1.50+163.3%-62.6%$85.41M$31.28M-0.92160Negative NewsTSETrinseo1.1774 of 5 stars$2.21-5.8%N/A-43.0%$79.27M$3.51B-0.202,950Positive NewsALTOAlto Ingredients3.5011 of 5 stars$1.03-1.9%$5.50+434.0%-28.3%$78.91M$965.26M-1.12420Positive NewsZTEKZentek0.5023 of 5 stars$0.71-0.4%N/A-31.6%$74.03M$1.22M-14.1424Gap DownLOOPLoop Industries1.4866 of 5 stars$1.40-2.1%N/A+5.0%$66.81M$11.14M-5.0090BLGOBioLargoN/A$0.19-0.9%N/A-16.7%$57.96M$12.23M-18.8230 Related Companies and Tools Related Companies AMTX Alternatives VGAS Alternatives FSI Alternatives LODE Alternatives ORGN Alternatives TSE Alternatives ALTO Alternatives ZTEK Alternatives LOOP Alternatives BLGO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBUS) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cibus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access